BEIJING NORTHLAND BIOTECH
Beijing Northland Biotech is a R&D high-tech enterprise mainly engaged in the development of therapeutic biological products.The company is a key high-tech enterprise of the National Torch Program, Beijing Science and Technology Research and Development Agency, Beijing Rare Plasmid Gene Therapy Drug Engineering Technology Research Center, and Beijing Biomedical Industry G20 Innovation Leading Enterprise with a registered capital of 112.167.676 million yuan. , stock code 430047.
BEIJING NORTHLAND BIOTECH
Industry:
Biotechnology
Founded:
2004-06-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.northland-bio.com
Status:
Active
Technology used in webpage:
SPF Ubuntu Alibaba HiChina DNS China Unicom
Similar Organizations
BioGend Therapeutics
BioGend Therapeutics is a medical equipment company mainly engaged in the development of biological aggregate.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Prosperous Biopharm
Prosperous Biopharm is a high-tech enterprise engaged in the development of bio - innovation drugs in Zhongguancun.
RE-Stem Biotech
RE-Stem Biotech is a high-tech enterprise jointly founded by Chinese and American biologists and medical scientists.
Investors List
GGR Capital
GGR Capital investment in Venture Round - Beijing Northland Biotech
Tengye Ventures
Tengye Ventures investment in Venture Round - Beijing Northland Biotech
Official Site Inspections
http://www.northland-bio.com
Unable to get host informations!!!
More informations about "Beijing Northland Biotech"
组织架构_北京诺思兰德生物技术股份有限公司
Apr 22, 2021 组织架构-北京诺思兰德生物技术股份有限公司北京诺思兰德生物技术股份有限公司是一家专业从事基因治疗药物、重组蛋白质类药物和眼科用药物研发、生产及销售的创新型生 …See details»
Beijing Northland Biotech - Crunchbase Company Profile & Funding
Beijing Northland Biotech is a R&D high-tech enterprise mainly engaged in the development of therapeutic biological products.The company is a key high-tech enterprise of the National …See details»
Northland Biotech 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Northland Biotech. Use the PitchBook Platform to explore the full profile.See details»
Beijing Northland Biotech. Co., Ltd. - LinkedIn
Beijing Northland Biotech. Co., Ltd. was established in June, 2004. Our main business is R&D of novel bio-medicines and the industrialization of ophthalmic products. We are listed on NEEQ …See details»
Beijing Northland Biotech Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Beijing Northland Biotech Co., Ltd. of Beijing, Beijing. Get the latest business insights from Dun & …See details»
Beijing Northland Biotech.Co., Ltd. - synapse.zhihuiya.com
了解Beijing Northland Biotech.Co., Ltd. (北京诺思兰德生物技术股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的17项临床试验和6篇文献，疾病领域:血液及淋巴系统疾病，内分 …See details»
诺思兰德-动脉网 - vbdata.cn
Jun 3, 2004 北京诺思兰德生物技术股份有限公司是一家专业从事基因治疗药物、重组蛋白质类药物和眼科用药物研发、生产及销售的创新型生物制药企业。公司成立于2004年6月，是北京证 …See details»
Beijing Northland Biotech Company Profile - Craft
See insights on Beijing Northland Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Beijing Northland Biotech. Co., Ltd. - SignalHire
Beijing Northland Biotech. Co., Ltd. was established in June, 2004. Our main business is R&D of novel bio-medicines and the industrialization of ophthalmic products. We are listed on NEEQ …See details»
公司简介_北京诺思兰德生物技术股份有限公司
Apr 22, 2021 北京诺思兰德生物技术股份有限公司是一家专业从事基因治疗药物、重组蛋白质类药物和眼科用药物研发、生产及销售的创新型生物制药企业。公司成立于2004年6月，2021 …See details»
热烈庆祝诺思兰德在北交所成功上市_北京诺思兰德生物制药有限公司
Nov 19, 2021 文章来源：详细新闻详见生物技术网站http://www.northland-bio.com/news/421.html 2021年11月15日，北京证券交易所鸣锣开市，母公司生物技术在北交 …See details»
Beijing Northland Biotech.Co., Ltd. - Drug pipelines, Patents
Apr 1, 2025 Explore Beijing Northland Biotech.Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 17 clinical trials, and 6 literature, Disease Domain:Hemic ...See details»
Northland Bioscience - Drug pipelines, Patents, Clinical trials
Explore Northland Bioscience with its drug pipeline, therapeutic area, technology platform, .See details»
基因治疗1类创新药申报上市，诺思兰德生物研发！医药新闻-ByDru…
⌈ByDrug医药新闻摘要⌋ 2024-07-13 09:03，细胞与基因治疗领域：今日（7月13日），中国国家药监局药品审评中心（CDE）官网公示， 北京诺思兰德生物技术股份有限公司（下称： 诺思兰 …See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 Building a world-class facility for biomanufacturing, clean tech Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a …See details»
北京诺思兰德生物技术股份有限公司 - northland-bio.com
关于我们 北京诺思兰德生物技术股份有限公司是一家专业从事基因治疗药物、重组蛋白质类药物和眼科用药物研发、生产及销售的创新型生物制药企业。公司成立于2004年6月，是国家火炬计 …See details»
诺思兰德荣获“第八届北交所&新三板企业风云际会”多项殊荣_北京 …
2024年12月19日，”2024并购重组助力创新型企业高质量发展论坛暨第八届北交所&新三板企业风云际会”在北京成功举行，会上发布了2024年度北交所和新三板评选优秀榜单。诺思兰德凭借 …See details»
Subject: Biology - MyNorthland
Docuseek’s Essential Collection provides streaming access to 800 video documentaries on social and environmental issues. The platform provides exclusive access…See details»
诺思兰德获准设立博士后科研工作站，培养高端专业人才_北京诺思 …
Dec 12, 2024 诺思兰德获准设立博士后科研工作站，培养高端专业人才 【概要描述】 2024年12月12日，由北京市人力资源和社会保障局主办的年度博士后人才培养工作会议在北京国际 …See details»
诺思兰德受邀参加韩国国际生物论坛 分享NL003Ⅲ期临床试验关键 …
Feb 23, 2025 诺思兰德受邀参加韩国国际生物论坛 分享NL003Ⅲ期临床试验关键结果-北京诺思兰德生物技术股份有限公司-2025年2月19日至21日，由韩国经济新闻主办的“HANKYUNG BIO …See details»